Clinuvel Pharmaceuticals Ltd 2025 Annual Report
Company: Clinuvel Pharmaceuticals Ltd
Sector: Manufacturing
Country: Australia
Year: 2025
Type: Annual Report
Pages: 159
The report presents FY2025 as the Group's ninth consecutive year of revenue growth and profitability, with consolidated total revenues, interest and other income of 105.300 A$ million. It sets out an ESG framework covering social fairness and equity, environmental responsibility, and governance. The company reports no injuries or time lost from workplace accidents and describes a workforce of about 100, while quantitative environmental measures and targets have not been set.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.